摘要
目的:研究地塞米松对低温等离子消融治疗扁桃体肥大的临床疗效。方法:选取扁桃体三度肥大合并睡眠通气障碍的患者150例,单纯随机抽样,分为地塞米松组与对照组,各75例,记录术中出血量,比较术后7 d疼痛视觉(VAS)评分。可视喉镜复查两组术后出血者伤口白膜形成情况。结果地塞米松组低温等离子术后7 d VAS评分(2.3±0.3)比对照组术后(7.0±0.2分)少,AHI指数前后均数分别为20±1.50、18±1.30。差异无统计学意义(P>0.05)。地塞米松组术后出血6例,出血率8%,对照组术后出血3例,出血率4%,可视喉镜复查白膜发现地塞米松组白膜形成时间较对照组延迟。结论:地塞米松可有效减少术后疼痛视觉评分,术后喉部适感有所减轻。但影响白膜形成的完整性,有可能等离子射频治疗扁桃体肥大增加术中出血发生率。地塞米松不影响睡眠通气障碍患者低通气指数。
Objective To study the dexamethasone( DXM) clinical effects of plasma radiofrequency on tonsillectomy and palatopharyngoplasty( PPP). Method A cohort study was applied both in Apnea hypopnea index( AHI) and Visual Analogue Scale( VAS) of post surgery 7 days,150 cases of tonsil hypertrophy involed in this stuy,all of them used Arthro Care radiofrequency to divide tissue and coagulate vessels. Results post- 7 days the VAS within DXM group mean( 2. 3 ± 0. 3) while( 7. 0 ± 0. 2) recorded in control group. AHI reduced as much as 50% 1 month later. Of 150 cases,the Postoperative bleeding happen to reach the amount of 9. Conclusion DXM reduce plasma radiofrequency tonsillectomy VAS in post- 7 days,in the contray,it may not reduce AHI of the tonsil hypertrophy patients.
出处
《吉林医学》
CAS
2016年第10期2426-2427,共2页
Jilin Medical Journal
关键词
地塞米松
扁桃体切除术
低温等离子射频
低通气指数
Dexamethasone
Tonsillectomy
Temperature-Controlled Radiofrequency
Apnea hypopnea index